Episode 4. Hepatitis C with Dr Ferry Rusli

In this episode I have a conversation with hepatologist and gastroenterologist Dr Ferry Rusli in a four-part series on liver disease where we explore chronic hepatitis C, its population reservoirs in Australia and approaches to treatment. In particular, Ferry points out - · The need to increase our effectiveness at treating hepatitis C in at risk populations.

In this episode I have a conversation with hepatologist and gastroenterologist Dr Ferry Rusli in a four-part series on liver disease where we explore chronic hepatitis C, its population reservoirs in Australia and approaches to treatment.

In particular, Ferry points out –

· The need to increase our effectiveness at treating hepatitis C in at risk populations (e.g. prison population)

· Discusses the impressive breakthrough with new antiviral therapies and their effectiveness in curing hepatitis C

· Surveillance for hepatocellular carcinoma

I really hope you find this conversation as interesting as I did.

Useful references include -

www.gesa.org.au

www.hep-druginteractions.org

www.hepatitisaustralia.com

www.gihealth.com.au

To be a guest on the show or provide some feedback, I’d love to hear from you: manager@gihealth.com.au

Dr Luke Crantock MBBS, FRACP, is a gastroenterologist in practice for over 25 years. He is the founder of The Centre for GI Health, based in Melbourne Australia and is passionate about educating General Practitioners and patients on disease prevention and how to manage and improve their digestive health.

Previous
Previous

Episode 5. COVID-19 with Dr Babak Rad

Next
Next

Episode 3. Hepatitis B with Dr Ferry Rusli